Outlook Therapeutics (OTLK) Long-Term Debt Repayments (2015 - 2025)
Outlook Therapeutics (OTLK) recorded Long-Term Debt Repayments of $2.33 million in fiscal Q4 2025 (quarter ended Sep 30, 2025), up 156.4% from the prior quarter.
Outlook Therapeutics (OTLK) Long-Term Debt Repayments (2015 - 2025) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Long-Term Debt Repayments of $36.14 million.
- Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 167.6% (FY2020 to FY2025).
- Across earlier fiscal years, Long-Term Debt Repayments came in at $4,267 in FY2024 (-100.0%), $10.23 million in FY2023 (-16.9%), $12.32 million in FY2022 (+233.6%) and $3.69 million in FY2021.
- The fiscal Q4 2025 figure is the highest quarterly Long-Term Debt Repayments since fiscal Q1 2023.
- The year-over-year decline in Long-Term Debt Repayments has ranged between 35.7% (fiscal Q4 2021) and 100.0% (fiscal Q3 2023) over the last five years.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 906,977.00 |
| Mar 31, 2024 | 1,084.00 |
| Dec 31, 2023 | 3,183.00 |
| Sep 30, 2023 | 3,082.00 |
| Jun 30, 2023 | 2,983.00 |
| Mar 31, 2023 | 2,889.00 |
| Dec 31, 2022 | 10.22 Mn |
| Sep 30, 2022 | 5,685.00 |
| Jun 30, 2022 | 11.60 Mn |
| Mar 31, 2022 | 308,327.00 |
| Dec 31, 2021 | 408,668.00 |
| Sep 30, 2021 | 19,722.00 |
| Jun 30, 2021 | 19,232.00 |
| Mar 31, 2021 | 18,755.00 |
| Dec 31, 2020 | 3.63 Mn |
| Sep 30, 2020 | 30,685.00 |
| Jun 30, 2020 | 30,420.00 |
| Mar 31, 2020 | 135,600.00 |
| Dec 31, 2019 | 66,571.00 |
Outlook Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();